CHICAGO, IL — January 20, 2026 — Gillson Sciences, a leader in analytical laboratory testing and scientific solutions, announced their partnership with SanAir Technologies Laboratory, Inc. (SanAir), an accredited and diversified environmental testing laboratory specializing in analytical and consulting services. While Gillson Sciences has built its foundation serving life sciences clients, this acquisition represents a deliberate step toward a broader, integrated focus on human health. Environmental factors play a critical role in long‑term health outcomes, influencing everything from water and air quality to food systems and community safety. By adding environmental testing capabilities, Gillson Sciences is expanding its mission to help prevent, protect, and defend against disease, addressing risks earlier in the health continuum.

“This partnership strengthens our commitment to advancing public health and safety by expanding our environmental testing and consulting services portfolio,” said Jason Fischer, CEO of Gillson Sciences. “Human health isn’t only influenced by clinical or laboratory interventions but also by the environmental conditions in which individuals live, work, and eat.” The addition of SanAir allows us to apply the same scientific rigor, quality standards, and client‑focused approach we bring to life sciences testing to the environmental factors that shape health outcomes every day.”

SanAir brings decades of expertise, a reputation for accuracy and reliability, and a proven track record of client-focused service to a range of environmental industry verticals nationally and internationally. Its environmental testing capabilities in air (including VOCs; soil vapor intrusion; LEED®, WELL®, IAQP, IgCC® certification systems; biogas; and industrial hygiene), asbestos, environmental microbiology, bacteria, lead and metals, material science, and Legionella, align directly with Gillson Sciences’ mission to provide science‑driven insights that protect human health and the environment.

SanAir will continue to operate under its established name, ensuring continuity of service for existing clients while benefiting from Gillson Sciences’ resources, innovation, and global reach.

SanAir’s President, Sean McGlynn, added, “Joining Gillson Sciences allows us to scale our impact, expand our service offerings, and continue delivering the trusted expertise that is so vital to our clients. Together, we are positioned to expand our reach and set new standards in environmental testing and consulting.”

The combined platform now supports clients across health & life sciences, nutritional science, and environmental science with a shared mission: advancing and protecting human health. The acquisition underscores Gillson Sciences’ long‑term growth strategy, reinforcing its leadership in scientific services and expanding its footprint in environmental health and safety.

About Gillson Sciences

Headquartered in Chicago, IL, Gillson Sciences advances human health by delivering the scientific rigor, insight, and partnership innovators need to create safer and more effective solutions—across life sciences and the environments where people live, work, and thrive. As a leader in laboratory testing, environmental testing, and scientific advisory solutions, we unite deep expertise with cutting‑edge technology to help organizations navigate complexity, reduce risk, and accelerate progress.

With an expanding team across the U.S., we are driven by a commitment to protect and improve human health. Our vision is a world where science empowers healthier lives and where trusted data, thoughtful collaboration, and relentless innovation shape a safer future for all. ISO 17025/GMP

About SanAir

Based in Richmond, Virginia, SanAir’s specialties have expanded to include analytical and consulting services, as well as environmental testing capabilities in air (including VOCs; soil vapor intrusion; LEED®, WELL®, IAQP, and IgCC® certification systems; biogas; and industrial hygiene), asbestos, environmental microbiology, bacteria, lead and metals, material science, Legionella, and other environmental hazards. SanAir’s clientele includes industrial hygienists, engineers, government agencies, and restoration and remediation contractors.

SanAir (LAP‑162952) is accredited by the AIHA Laboratory Accreditation Programs, LLC (AIHA LAP) in Environmental Microbiology, Environmental Lead, and Industrial Hygiene. All accredited fields of testing employ approved and standardized procedures to maintain quality and data integrity in accordance with strict AIHA LAP guidelines, ISO/IEC 17025:2017, and EPA NLLAP LQSR Rev 4.0 standards.

For more information, please visit www.sanair.com.

Media Contact:
Kristen Dallman
Director of Marketing & Brand
Gillson Sciences
press@gillsonsciences.com

A successful Environmental Monitoring Performance Qualification (EMPQ) is critical to maintaining control of your manufacturing environment. Yet, many organizations underestimate the time, resources, and coordination required to complete the process efficiently.

In this whitepaper, Gillson Sciences Manager of Global Operations, Erin Thane, outlines the essential steps for achieving EMPQ readiness—from understanding regulatory expectations and cleanroom classifications to aligning stakeholders, defining test parameters, and minimizing downtime.

You’ll learn:

• What regulators expect from EMPQ design and documentation
• How to build a realistic EMPQ timeline and minimize disruptions
• Common pitfalls that delay qualification efforts

Gillson Sciences is proud to announce that Tim Bochula, President, has been appointed to serve on one of the United States Pharmacopeial Convention (USP)’s prestigious Expert Committees for the 2025–2030 cycle. This appointment acknowledges Tim’s profound scientific expertise and dedication to advancing global standards for high-quality medicines and ingredients.

USP officially announced the rosters of its 28 Expert Committees on July 16, 2025, selecting over 350 distinguished volunteers from a competitive pool of nearly 5,000 applicants across 128 countries. These committees play a vital role in USP’s mission to improve public health by developing and maintaining rigorous standards for medicines, dietary supplements, and food ingredients used worldwide.

Tim will contribute to USP’s standards-setting process alongside other scientific leaders, FDA liaisons, and global regulators. His committee assignment reflects Gillson Sciences’ growing influence in pharmaceutical innovation and quality assurance. USP standards are recognized in more than 140 countries and published in compendia such as the U.S. Pharmacopeia–National Formulary (USP–NF), the Food Chemicals Codex (FCC), and the Herbal Medicines Compendium (HMC).

“We’re thrilled to see Tim’s expertise recognized at this level,” said Gillson Sciences CEO, Jason Fischer. “His appointment underscores our commitment to scientific rigor and global collaboration in ensuring the safety and efficacy of the products consumers rely on.”

Tim’s participation will help shape the future of pharmaceutical quality, contributing to USP’s efforts to address evolving challenges in medicine development, regulation, and distribution. His appointment also reinforces Gillson Sciences’ dedication to advancing public health through science-driven leadership.

For more information about USP’s Expert Committees and their work, visit USP’s official announcement.

Gillson Sciences is proud to announce its official formation, marking a significant milestone in the evolution of scientific services that support quality, safety, and regulatory excellence across the healthcare ecosystem. Gillson combines deep expertise in laboratory testing, monitoring, and advisory services to empower clients across the pharmaceuticals, biopharma, medical devices, healthcare, and environmental sciences sectors.

Formed in January 2025, Gillson Sciences unites two industry leaders—Azzur Labs (now Gillson Testing) and Micro Measurement Laboratories (MML)—to deliver comprehensive, science-driven solutions across the product lifecycle. With GMP-compliant laboratories in Pennsylvania, Illinois, and California, and field personnel nationwide, Gillson is positioned to serve clients with precision, integrity, and responsiveness.

Jason Fischer has been named CEO, bringing over a decade of leadership experience from UL Solutions, where he spearheaded strategic growth through partnerships and more than 40 acquisitions. His vision for Gillson is clear: “Gillson Sciences represents the opportunity to build a market leader in testing, monitoring, and advisory solutions focused on advancing human health,” said Fischer. “We have a great foundation with our outstanding employees and clients, a motivating mission, and the right partners to deliver on our plan”.

Gillson’s mission is to support clients in developing, sourcing, manufacturing, and commercializing safe and effective products. Its services are considered mission-critical by regulatory bodies, enabling clients to maintain operations and meet stringent compliance demands.

Looking ahead, Gillson will continue to expand its capabilities within the testing, inspection, certification, and compliance (TICC) sector. The company is actively seeking partnerships with organizations that share its commitment to scientific excellence and regulatory integrity.